Brand Name - Dectomax (Doramectin) 500mL Injectable Solution

The USDA Animal and Plant Health Inspection Service (APHIS) seeks 2,400 bottles of Dectomax (doramectin) 500 mL injectable solution through a brand-name-only combined synopsis/solicitation, with quotations due October 30, 2026. The acquisition is a Total Small Business set-aside, and the attached brand-name justification for other-than-full-and-open competition restricts the requirement to Dectomax because no alternative injectable doramectin is available. Alternate or equal products will be rejected.

Delivery is to the USDA APHIS VS TICK OFFICE at 7209 E Saunders Suite 4, Laredo, TX 78041, within 30 days of contract award, F.O.B. destination, with a separate lump-sum delivery charge. The requirement supports APHIS's Cattle Fever Tick Eradication Program (CFTEP) in Texas and New World Screwworm response operations. The justification estimates contract value at $400,800, and APHIS will solicit quotes from multiple authorized Dectomax distributors, including small business distributors.

Offerors must provide the exact brand, make, and model, with documentation confirming the product is new and unrefurbished. Products must trace to the original equipment manufacturer, Zoetis Inc., with a Certificate of Conformance under FAR 52.246-15 and Buy American compliance under FAR 52.225-1. Offerors must hold prices firm for 90 calendar days from receipt.

Award will be a firm-fixed-price contract to a single offeror, based on the lowest price among technically acceptable offers. Past performance is rated acceptable, neutral, or unacceptable. If the lowest-priced offer is technically unacceptable, evaluation proceeds sequentially to the next offer. Questions were due October 21, 2026, at 12:00 PM MDT, and Amendment 00001 is posted. The protest process has two tiers, with agency-level protests resolved within 35 business days. The NAICS code is 325414, and the PSC is 6509.